Identification of Cx43 variants predisposing to ventricular fibrillation in the acute phase of ST-elevation myocardial infarction
ConclusionConnexin 43 variants are associated with increased VF susceptibility in STEMI patients. Restoring Cx43 function may be a potential therapeutic target to prevent PVF in patients with acute MI.Clinical trial registrationClinical Trial Registration:https://clinicaltrials.gov/ct2/show/NCT00859300
Source: Europace - Category: Cardiology Source Type: research
More News: Atrial Fibrillation | Beta-Blockers | Cardiology | Clinical Trials | Genetics | Heart Attack | Study